PEAK6 Investments LLC Has $384,000 Stake in Core Laboratories Inc. (NYSE:CLB)

PEAK6 Investments LLC trimmed its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 65.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,750 shares of the oil and gas company's stock after selling 39,910 shares during the quarter. PEAK6 Investments LLC's holdings in Core Laboratories were worth $384,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLB. FMR LLC boosted its position in Core Laboratories by 182.9% in the third quarter. FMR LLC now owns 17,057 shares of the oil and gas company's stock valued at $316,000 after buying an additional 11,028 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Core Laboratories in the third quarter valued at approximately $211,000. The Manufacturers Life Insurance Company boosted its holdings in shares of Core Laboratories by 19.1% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 21,511 shares of the oil and gas company's stock worth $399,000 after acquiring an additional 3,457 shares in the last quarter. Fisher Asset Management LLC grew its position in Core Laboratories by 19.5% during the 3rd quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company's stock worth $18,350,000 after acquiring an additional 161,278 shares during the last quarter. Finally, Eagle Asset Management Inc. acquired a new stake in Core Laboratories during the 3rd quarter valued at $3,531,000. 97.81% of the stock is owned by institutional investors.

Core Laboratories Stock Down 0.2 %

NYSE:CLB traded down $0.05 on Thursday, hitting $20.12. 54,051 shares of the company's stock were exchanged, compared to its average volume of 414,570. The firm has a 50-day moving average price of $19.59 and a 200-day moving average price of $19.61. Core Laboratories Inc. has a 52 week low of $13.82 and a 52 week high of $25.13. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. The company has a market cap of $944.63 million, a P/E ratio of 31.03, a price-to-earnings-growth ratio of 1.39 and a beta of 2.35.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.04. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The business had revenue of $134.40 million for the quarter, compared to analysts' expectations of $134.16 million. During the same quarter in the prior year, the business earned $0.22 EPS. The firm's revenue for the quarter was up 7.2% on a year-over-year basis. As a group, analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were given a $0.01 dividend. The ex-dividend date was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.20%. Core Laboratories's dividend payout ratio is currently 6.15%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on CLB shares. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Citigroup lowered their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a research report on Thursday, October 31st. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $17.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.